ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IMNM vs PRGO // EV/EBITDA & P/E VALUATION

Immunome Inc. (NASDAQ) VS. Perrigo Company plc (NYSE) • 15-METRIC TALLY: IMNM 1 — PRGO 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMNM VS. PRGO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IMNM PRGO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 35.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -13.60% -21.40 PRGO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -9.29% 6.58% -15.87 PRGO /fcf-yield <GO>
Operating Margin -60.00% -26.40% -33.60 PRGO /operating-margins <GO>
Net Profit Margin -60.00% -33.50% -26.50 PRGO /net-margins <GO>
Revenue Growth (YoY) -23.20% -2.80% -20.40 PRGO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 7.22% -7.22 PRGO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 25.03 0.20 +24.83 IMNM /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 PRGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.7 54.8 -15.10 PRGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.15B $2.19B -$40.9M PRGO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IMNM REV PRGO REV IMNM GROSS % PRGO GROSS % IMNM FCF PRGO FCF
FY 2025 $6.9M $4.25B — 35.1% -$200.6M $145.1M
FY 2024 $9.0M $4.37B — 35.3% -$118.0M $244.6M
FY 2023 $14.0M $4.66B — — -$7.6M $405.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMNM // BETA —
PRGO // BETA —